Sorry, you need to enable JavaScript to visit this website.

January Social Media Round-Up—Celebrating 175, Discussing AI, and Attending CES 2024

image of Forture award, world's most admired companies 2023

One month into the new year and Pfizer is already got plenty to show for it.

January’s social media round-up features a dispatch from Las Vegas’s CES conference, our CTO’s insight into artificial intelligence’s impact on cancer, and an impassioned pleas from our CEO.

Catch up below:

CEO Albert Bourla kicks off Pfizer’s 175th anniversary celebration:

https://www.linkedin.com/posts/albert-bourla_2024-marks-a-significant-year-for-pfizer-activity-7150126029393580032-ES_A?utm_source=share&utm_medium=member_desktop

Chief People Experience Office Payal Sahni Becker celebrates Pfizer’s inclusion on Fortune’s Most Admired Companies list:

https://www.linkedin.com/feed/update/urn:li:activity:7159211335610699776/

CEO Albert Bourla TIME Op-Ed urging action for Israeli hostages in Gaza:

https://www.linkedin.com/posts/albert-bourla_column-my-call-to-action-for-the-israeli-activity-7155195894412230656-x3i4?utm_source=share&utm_medium=member_desktop

Chief Marketing Officer Drew Panayiotou reports back on his experience at CES 2024:

https://www.linkedin.com/posts/drewpanayiotou_ces2024-ai-activity-7151732623998930944-45mi

CEO Albert Bourla lists some of the company’s 2023 highlights:

https://www.linkedin.com/posts/albert-bourla_pfizerproud-activity-7158185661068427266-WWcI

Chief Digital and Technology Officer Lidia Fonseca shares her discussion with Forbes about AI’s impact on healthcare and the future of cancer treatment:

https://www.linkedin.com/feed/update/urn:li:activity:7159219986593386496